Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort
Author(s) -
Anthony J. Swerdlow,
Rosie Cooke,
Dominique Beckers,
Gary Butler,
JeanClaude Carel,
Stefano Cianfarani,
Peter Clayton,
Joël Coste,
Annalisa Deodati,
Emmanuel Écosse,
Anita Hokken-Koelega,
Aysha J. Khan,
Wieland Kieß,
Claudia E. Kuehni,
Christa E. Flück,
Roland Pfäffle,
Lars Sävendahl,
Grit Sommer,
Muriel Thomas,
Anders Tidblad,
Sally Tollerfield,
Gladys R.J. Zandwijken
Publication year - 2018
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2018-01133
Subject(s) - medicine , meningioma , radiation therapy , cohort , context (archaeology) , cohort study , incidence (geometry) , absolute risk reduction , relative risk , pediatrics , surgery , oncology , confidence interval , paleontology , physics , optics , biology
There has been concern that GH treatment of children might increase meningioma risk. Results of published studies have been inconsistent and limited.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom